Vinorelbine (N)-capecitabine (C) combination in advanced breast cancer (ABC): Long-term results of two multicentric phase II trials

2005 ◽  
Vol 23 (16_suppl) ◽  
pp. 673-673 ◽  
Author(s):  
M. Ghosn ◽  
G. Chahine ◽  
J. Kattan ◽  
F. Farhat ◽  
F. Nasr ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Advanced Breast ◽  
Long Term Results ◽  
Phase Ii Trials

Sequential vinorelbine–capecitabine followed by docetaxel in advanced breast cancer: long-term results of a pilot phase II trial

2007 ◽  
Vol 62 (1) ◽  
pp. 11-18 ◽  
Author(s):  
Marwan Ghosn ◽  
Joseph Kattan ◽  
Fadi Farhat ◽  
Fariha Younes ◽  
Fadi Nasr ◽  
...  
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Phase Ii ◽  
Phase Ii Trial ◽  
Advanced Breast ◽  
Long Term Results ◽  
Pilot Phase

Multimodality Treatment of Locally-Advanced Breast Cancer Using 6.3 MeV Fast Neutrons and Quality of Life in Patients in Long-Term Follow-Up

2015 ◽  
Vol 1084 ◽  
pp. 406-408
Author(s):  
Zhanna Startseva ◽  
Ludmila Musabaeva ◽  
Valerij Lisin
Keyword(s):  
Breast Cancer ◽  
Advanced Breast Cancer ◽  
Locally Advanced Breast Cancer ◽  
Locally Advanced ◽  
Multimodality Treatment ◽  
Advanced Breast ◽  
Long Term Results ◽  
Fast Neutrons ◽  
Combined Modality Treatment

The purpose of the study is to present the 10-year results of the combined modality treatment with the use of neutron-photon therapy for patients with T2-4N0-2M0 locally advanced breast cancer (LABC). The study involved 246 LABC patients (T2-4N0-2M0). Analysis of long-term results of multimodality treatment of patients with primary LABC has shown that preoperative neutron therapy is the most effective in the presence of multicentric tumors, radioresistance to neoadjuvant chemotherapy and other adverse prognostic factors.

Sign in / Sign up

Export Citation Format

Share Document